Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT04381611

INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register

The study is an observational analysis of patients' medical data recorded in a large-scale register, both retrospective (for patients operated and data recorded before 2018) and prospective (for data collected after 2018) in nature.Patients' medical data contained in the register will be analysed to determine the efficacy of the treatments they received during their follow-up at the investigation centre.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

About this study

This study involves the creation and analysis of a large-scale register including all patients suffering from glaucoma, currently and previously followed-up and treated at a single tertiary centre in Lausanne, Switzerland. The design of the study is longitudinal, observational and comparative. Patients are recruited retrospectively if they attended the research centre before September 2018, and prospectively if they attend the centre from this month onwards. Their inclusion does not affect their care, treatment choice or follow-up. All data of recruited patients is be kept in their medical notes until a specific analysis is launched. Data is then exported from their medical notes into a coded database for analysis. At the end of each analysis session (defined as the publication of the related article), all exported data is fully anonymised.

Data analysis will aim to assess the long-term efficacy, safety profile, and factors predictive of success/failure of treatments performed.

To ensure the quality of all included data, health-related information will be extracted directly from the medical notes and coded into the register by a Clinical Research Associate. Conformity of the process and recorded data will be confirmed by regular internal auditing. For quality assurance the Ethics Committee may visit the research sites. Direct access to the source data and all project related files and documents must be granted on such occasions.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of glaucoma (open-angle, closed-angle, primary or secondary) or ocular hypertension (IOP > 24 mmHg, medicated or not)
  • Patients who received treatment (medical, laser or surgical) at the Glaucoma Centre, Montchoisi Clinic
  • Able and willing to provide informed written or verbal consent

Exclusion criteria

  • Patient who are unable to understand the implications of their inclusion in the study or who are unable or unwilling to give informed consent

Treatment and study plan

Primary outcomes

  1. Number of patients with IOP reduction mmHg

    Time frame: 12 month

    Final Intra Ocular Pressure <20% compared to baseline

  2. Patients with quantitative OCT variations ( RNFL, μm)

    Time frame: 12 month

    Variation of RNFL before and after treatment ( laser, surgery, drug..)

  3. Number of patients with quantitative VF variation ( MD, dB)

    Time frame: 12 month

    Visual Field MD variation before and after treatment ( laser, surgery, drug..)

  4. Number of patients with quantitative VF variation (LV, dB)

    Time frame: 12 months

    Visual Field MD variation before and after treatment ( laser, surgery, drug..)

Secondary outcomes

  1. Number of operations received by a patients

    Time frame: 12 month

    Number of operations undertaken by each patient

  2. Number of patients undergoing a specific ocular surgical or laser procedure

    Time frame: 12 month

    Number of patients undertaking different types of ocular procedures ( deep sclerectomy, cataract, LPI, SLT,...)

  3. Number of lowering IOP drugs ( molecules) taken by each patient

    Time frame: 12 month

    Number of molecules used by each patient (e.g Cosopt: 2 molecules, Xalatan: 1...)

  4. Anterior segment OCT variations: ACA (°), SSA (°)

    Time frame: 12 month

    variations of these measurements before and after procedure ( surgery or laser)

  5. Anterior segment OCT variations: AOD (mm)

    Time frame: 12 month

    variations of these measurements before and after procedure ( surgery or laser)

  6. Anterior segment OCT variations: TISA (mm2)

    Time frame: 12 month

    variations of these measurements before and after procedure ( surgery or laser)

Sponsors and collaborators

Lead sponsor

Dr. Kaweh Mansouri

Other

Registry information

Important dates

Study start
2019
Primary completion
2030
Study completion
2030
First posted
May 11, 2020
Registry last updated
May 5, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.